IGF2BP3 and hepatocellular carcinoma: A further SROC analysis highlighted the potential of IGF2BP3 mRNA levels as a discriminatory biomarker between HCC and non-HCC conditions, demonstrating an area under the curve (AUC) value of 0.86 (95% CI = 0.83–0.89, Fig. S2).